|
 The company said it would pay $150 million and suspend at least
three distribution centers' registrations for two years in the least
as part of the settlement.
The U.S. Department of Justice was not immediately available for
comment.
The suspensions will not result in supply disruptions to any
customer, McKesson said in a regulatory filing on Thursday.
(http://1.usa.gov/1zhJqjY)
The company's pharmaceutical distribution of certain controlled
substances at its Landover, Maryland distribution center, was also
being investigated.
McKesson said it had already accounted for Thursday's settlement in
its financial year ended on March 31.
(Reporting by Vidya L Nathan in Bengaluru; Editing by Sriraj
Kalluvila)
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
